Bandaram Pharma Packtech Ltd vs Yatharth Hospital Trauma Care Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Bandaram Pharma Packtech Ltd is ₹ 18.81 as of 30 Oct 15:30 . The P/E Ratio of Bandaram Pharma Packtech Ltd changed from 155.2 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Yatharth Hospital & Trauma Care Services Ltd changed from 31.3 on March 2024 to 0 on March 2022 . This represents a CAGR of -100.00% over 5 years The Market Cap of Bandaram Pharma Packtech Ltd changed from ₹ 21.89 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 3582 crore on March 2024 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 5 years The revenue of Bandaram Pharma Packtech Ltd for the Sep '26 is ₹ 21.45 crore as compare to the Jun '26 revenue of ₹ 23.95 crore. This represent the decline of -10.44% The revenue of Yatharth Hospital & Trauma Care Services Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 397.01 crore. This represent the decline of -100% The ebitda of Bandaram Pharma Packtech Ltd for the Sep '26 is ₹ 1.16 crore as compare to the Jun '26 ebitda of ₹ 1.55 crore. This represent the decline of -25.16% The ebitda of Yatharth Hospital & Trauma Care Services Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 96.04 crore. This represent the decline of -100% The net profit of Bandaram Pharma Packtech Ltd changed from ₹ 0.18 crore to ₹ 0.19 crore over 10 quarters. This represents a CAGR of 2.19% The net profit of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 30.38 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The Dividend Payout of Bandaram Pharma Packtech Ltd changed from 15 % on March 2023 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Yatharth Hospital & Trauma Care Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Bandaram Pharma Packtech Ltd

Bandaram Pharma Packtech Limited was initially established as Shiva Medicare Limited on December 2, 1991 to manufacture latex gloves.
The name of the Company was changed to Bandaram Pharma Packtech Limited from Shiva Medicare Limited on 7 March, 2022.
Since the year 2022, Company engaged in the business of trading of paper board and recycled waste paper.
But due to increased activity in this line of work, the computer sales and AMC business slowly became inoperative and the Company today has only one line of activity, viz, processing and supply of recycled paper. The Company supplies various categories of recycled paper, to small and medium size paper mills, located mainly in the East & West Godavari Districts of Andhra Pradesh.
This recycled paper consists of consumer waste paper such as old newspapers, notebooks and other textbooks, exercise books, forms and all types of discarded paper.

About Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services Limited was formerly incorporated as a Private Limited Company in Delhi dated February 28, 2008.
On November 3, 2021, the status converted into a Public Company and name of the Company was changed to Yatharth Hospital & Trauma Care Services Limited' on November 18, 2021 issued by the RoC. Yatharth Hospitals and Trauma Care Services Limited is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care. The Company operate three super specialty hospitals in Delhi NCR, i.e., at Greater Noida, Uttar Pradesh.
The super speciality tertiary care hospital currently operates with 400 beds, including 112 critical care beds and 9 modular operation theatres, among other surgical facilities.

FAQs for the comparison of Bandaram Pharma Packtech Ltd and Yatharth Hospital & Trauma Care Services Ltd

Which company has a larger market capitalization, Bandaram Pharma Packtech Ltd or Yatharth Hospital & Trauma Care Services Ltd?

Market cap of Bandaram Pharma Packtech Ltd is 33 Cr while Market cap of Yatharth Hospital & Trauma Care Services Ltd is 8,942 Cr

What are the key factors driving the stock performance of Bandaram Pharma Packtech Ltd and Yatharth Hospital & Trauma Care Services Ltd?

The stock performance of Bandaram Pharma Packtech Ltd and Yatharth Hospital & Trauma Care Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bandaram Pharma Packtech Ltd and Yatharth Hospital & Trauma Care Services Ltd?

As of October 31, 2026, the Bandaram Pharma Packtech Ltd stock price is INR ₹18.81. On the other hand, Yatharth Hospital & Trauma Care Services Ltd stock price is INR ₹928.05.

How do dividend payouts of Bandaram Pharma Packtech Ltd and Yatharth Hospital & Trauma Care Services Ltd compare?

To compare the dividend payouts of Bandaram Pharma Packtech Ltd and Yatharth Hospital & Trauma Care Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.